A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer. - Waks AG; Desai NV; Li T; Poorvu PD; Partridge AH; Sinclair N; Spring LM; Faggen M; Constantine M; Metzger O; Alberti J; Deane J; et al. (NPJ breast cancer, 2022)